Abstract:Background: The global probiotics dietary supplements market size is continuously growing. To overcome probiotics' health concerns, metabiotics are recognized as a safer alternative. Aiming to deal with the escalating antimicrobial resistance, the current work demonstrates synergistic metabiotic-antibiotic combinations against antibiotic-resistant pathogens. Methods: The probiotic properties of lactic acid bacteria (LAB) strains isolated from 3 commercial dietary supplements were characterized in vitro. The combinations of the cell-free supernatants (CFS) of selected probiotic strains and conventional antibiotics against Staphylococcus aureus and Escherichia coli clinical isolates were evaluated using the time-kill assay. To our knowledge, the current literature lacks sufficient time-kill assay studies revealing the kinetics of such metabiotic-antibiotic combinations against S. aureus and E. coli. Results: Four LAB strains isolated from dietary supplements as well as two reference strains were included in this study. The isolated LAB strains were identified by MALDI-TOF mass spectrometry as follows: P2: Lactobacillus acidophilus, P3: Lactiplantibacillus plantarum, P4: Lacticaseibacillus rhamnosus, and P5: Pediococcus acidilactici. The identification matched with that annotated by the manufacturers, except for P3. The tested strains could resist the acidic environment at pH 3. Excluding P2, the examined strains showed less than 1 log reduction in survivors upon the addition of reconstituted skimmed milk to pepsin at pH 2 and displayed an acceptable tolerance to 0.3% ox-bile. All the strains tolerated pancreatin. The hydrophobicity and autoaggregation capacities ranged between 7-92% and 36-66%, respectively. P2 was excluded owing to its inferior probiotic potential. Although the remaining strains showed excellent growth at 0.2% phenol, their growth was reduced at higher concentrations. L. plantarum and P. acidilactici strains possessed bile salt hydrolysis activity. The time-kill assay revealed promising synergistic activities of the combinations of CFS of L. rhamnosus P4 with either ceftazidime or gentamicin against E. coli and with only ceftazidime against S. aureus, as well as CFS of P. acidilactici P5 and ceftazidime against S. aureus. Conclusions: Strict identification and evaluation of the probiotic strains incorporated in dietary supplements is crucial to ensure their safety and efficacy. The CFS of probiotics could be utilized to formulate novel biotherapeutics targeting problematic pathogens. However, future in vivo studies are required to evaluate the appropriate treatment regimen.

The Genus Enterococcus: Between Probiotic Potential and Safety Concerns—An Update

Enterococci: Between Emerging Pathogens and Potential Probiotics

Evaluation of Enterococcal Probiotic Usage and Review of Potential Health Benefits, Safety, and Risk of Antibiotic-Resistant Strain Emergence

Emerging Risks in Food: Probiotic Enterococci Pose a Threat to Public Health through the Food Chain

Molecular Assessment and Validation of the Selected Enterococcal Strains as Probiotics

Safety Evaluation of Bifidobacterium Lactis BL-99 and Lacticaseibacillus Paracasei K56 and ET-22 in Vitro and in Vivo

Probiotic and Postbiotic Potentials of Enterococcus faecalis EF-2001: A Safety Assessment

The Many Faces of Enterococcus spp.—Commensal, Probiotic and Opportunistic Pathogen

Probiotic Properties of Enterococcus Isolated From Artisanal Dairy Products

Safety of probiotics--a review]

Pathogenic Potential and Antibiotic Susceptibility: A Comprehensive Study of Enterococci from Different Ecological Settings

In vitro Characterization of Enterococcus faecium strain LCM08 as a probiotic

Human and animal intestinal commensals and probiotics vs modern challenges of biosafety: problems and prospects

Probiotics interaction with foodborne pathogens: a potential alternative to antibiotics and future challenges

Safety Assessment of Enterococcus Lactis Based on Comparative Genomics and Phenotypic Analysis

Safety assessment of probiotics for human use

Probiotic Characteristics of Enterococcus spp Bacteria Isolated from Different Sources

Characterization of probiotics isolated from dietary supplements and evaluation of metabiotic-antibiotic combinations as promising therapeutic options against antibiotic-resistant pathogens using time-kill assay

Bacillus As Potential Probiotics: Status, Concerns, and Future Perspectives

Recent investigations and updated criteria for the assessment of antibiotic resistance in food lactic acid bacteria

Benefits and concerns of probiotics: an overview of the potential genotoxicity of the colibactin-producing Escherichia coli Nissle 1917 strain